Search

Author/Creator Zimmer, Jennifer A.

1. Clinically Negligible Pharmacokinetic and Pharmacodynamic Interactions Between Lanabecestat and Dabigatran Etexilate, a Prototypical P‐gp Substrate. (18th December 2019)

Authors:
Monk, Scott A.; Kugler, Alan R.; Andersen, Scott W.; Ayan‐Oshodi, Mosun A.; James, Douglas E.; Mullen, Jamie; Zimmer, Jennifer A.; Willis, Brian A.
Journal:
Journal of clinical pharmacology
Issue:
Volume 60:Number 5(2020)
Page Start:
586
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Disease progression and costs at 3‐year follow‐up of GERAS‐US: A 3‐year study of mild cognitive impairment and mild dementia due to Alzheimer's disease in the United States. (31st December 2021)

Authors:
Chandler, Julie; Rentz, Dorene M; Zagar, Anthony; Kim, Yongin; Zimmer, Jennifer A.; Schwartz, Ronald L.; Fillit, Howard
Journal:
Alzheimer's & dementia
Issue:
Volume 17(2021)Supplement 6
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. DT‐01‐04: LANABECESTAT: BASELINE CHARACTERISTICS OF PARTICIPANTS RANDOMIZED IN THE PHASE 2/3 AMARANTH STUDY. (1st July 2006)

Authors:
Sims, John R.; Downing, AnnCatherine M.; Andersen, Scott W.; Wessels, Alette M.; Zimmer, Jennifer A.; Mullen, Jamie; Schumi, Jennifer; Stern, Robert A.; Vellas, Bruno; Boada, Mercè; Cohen, Sharon; MacSweeney, Emer; Tariot, Pierre N.
Journal:
Alzheimer's & dementia
Issue:
Volume 14:Supplement 7(2018)Part 31
Page Start:
P1666
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease. Issue 1 (14th February 2021)

Authors:
Zimmer, Jennifer A.; Shcherbinin, Sergey; Devous, Michael D.; Bragg, Sonja M.; Selzler, Katherine J.; Wessels, Alette M.; Shering, Craig; Mullen, Jamie; Landry, John; Andersen, Scott W.; Downing, AnnCatherine M.; Fleisher, Adam S.; Svaldi, Diana Otero; Sims, John R.
Journal:
Alzheimer's & dementia
Issue:
Volume 7:Issue 1(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P1‐044: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of LY3202626, a Novel Bace1 Inhibitor, in Healthy Subjects and Patients with Alzheimer's Disease. (1st July 2016)

Authors:
Willis, Brian A.; Lowe, Stephen L.; Daugherty, Leslie L.; Dean, Robert A.; English, Brett; Ereshefsky, Larry; Gevorkyan, Hakop; James, Douglas E.; Jhee, Stanford; Lin, Qun; Lo, Albert; Mergott, Dustin J.; Monk, Scott A.; Nakano, Masako; Zimmer, Jennifer A.; Irizarry, Michael C.
Journal:
Alzheimer's & dementia
Issue:
Volume 12:Supplement 7S(2016)Part 8
Page Start:
P418
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗